Form 4 for TXG 10x Genomics, Inc.
Accepted 2024-08-26 00:00:00 ET · period of report 2024-08-22 · accession 0001610717-24-000455 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-26 | 2024-08-22 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $22.53 | -6,749 | 882.5K | -0.8% | -$152.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-08-22 | S | D | 6,749 | $22.53 | 882,467 | D | — | — |